Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
You can verify their registration online via the relevant regulator
Unlike earlier single or dual incretin-based therapies, Retatrutide is known as a triple hormone receptor agonist, acting simultaneously on GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
All analytes exhibited significantly better responses in positive ESI mode, consistent with the acidic mobile phase
Applied Clinical Trials Online, 2026
Scientific Background Current areas of scientific investigation include: Growth Hormone Secretagogue Receptor (GHSR-1a) The primary receptor studied in connection with Ipamorelin and its selective receptor-binding characteristics
US$ 25.96
US$ 22.28
US$ 22.88
US$ 22.56
US$ 20.58
